Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 12, 2017 - Issue
Submit an article Journal homepage
127
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD

Yueh Lan Huang1 Department of Internal Medicine, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City
,
Chih-Cheng Lai2 Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Tainan
,
Ya-Hui Wang3 Medical Research Center, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City
,
Cheng-Yi Wang1 Department of Internal Medicine, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei CityCorrespondence[email protected]
,
Jen-Yu Wang1 Department of Internal Medicine, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City
,
Hao-Chien Wang4 Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, TaipeiCorrespondence[email protected]
,
Chong-Jen Yu4 Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei
&
Likwang Chen5 Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Miaoli County, Taiwan
 show all
Pages 2987-2996 | Published online: 11 Oct 2017

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Konstantinos Kostikas, Chin Kook Rhee, John R Hurst, Piergiuseppe Agostoni, Hui Cao, Robert Fogel, Rupert Jones, Janwillem W H Kocks, Karen Mezzi, Simon Wan Yau Ming, Ronan Ryan & David B Price. (2020) Adequacy of Therapy for People with Both COPD and Heart Failure in the UK: Historical Cohort Study. Pragmatic and Observational Research 11, pages 55-66.
Read now
Samy Suissa & Pierre Ernst. (2018) Beta-Blockers in COPD: A Methodological Review of the Observational Studies. COPD: Journal of Chronic Obstructive Pulmonary Disease 15:5, pages 520-525.
Read now

Articles from other publishers (15)

Vincenzo Arcoraci, Francesco Squadrito, Michelangelo Rottura, Maria Antonietta Barbieri, Giovanni Pallio, Natasha Irrera, Alessandro Nobili, Giuseppe Natoli, Christiano Argano, Giovanni Squadrito & Salvatore Corrao. (2022) Beta-Blocker Use in Older Hospitalized Patients Affected by Heart Failure and Chronic Obstructive Pulmonary Disease: An Italian Survey From the REPOSI Register. Frontiers in Cardiovascular Medicine 9.
Crossref
Chang-Min Chung, Ming-Shyan Lin, Shih-Tai Chang, Po-Chang Wang, Teng-Yao Yang & Yu-Sheng Lin. (2022) Cardioselective Versus Nonselective β-Blockers After Myocardial Infarction in Adults With Chronic Obstructive Pulmonary Disease. Mayo Clinic Proceedings 97:3, pages 531-546.
Crossref
Katerina Baou, Vasiliki Katsi, Thomas Makris & Dimitris Tousoulis. (2021) Beta Blockers and Chronic Obstructive Pulmonary Disease (COPD): Sum of Evidence. Current Hypertension Reviews 17:3, pages 196-206.
Crossref
N. A. Karoli & A. P. Rebrov. (2021) Possibilities and limitations of the use of beta-blockers in patients with cardiovascular disease and chronic obstructive pulmonary disease. Kardiologiia 61:10, pages 89-98.
Crossref
Giulio Francesco Romiti, Bernadette Corica, Eugenia Pipitone, Marco Vitolo, Valeria Raparelli, Stefania Basili, Giuseppe Boriani, Sergio Harari, Gregory Y H Lip, Marco Proietti, Masaharu Akao, Tyler Warren Barrett, Mauro Campanini, Laurent Fauchier, Yutao Guo, Gualberto Gussoni, Bhautesh D Jani, Cathy A Jenkins, Mehmed Kulić, Frances Mair, Milena SorianoMarcolino, Nabil Naser, Emily C O'Brien, Hishashi Ogawa, Gabriela MM Paixão, Jonathan P Piccini, Antonio Luiz Ribeiro & Moisãs Rodriguez-Mañero. (2021) Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients. European Heart Journal 42:35, pages 3541-3554.
Crossref
Shivang Joshi, Stewart J. Tepper, Sylvia Lucas, Soeren Rasmussen & Rob Nelson. (2021) A narrative review of the importance of pharmacokinetics and drug–drug interactions of preventive therapies in migraine management. Headache: The Journal of Head and Face Pain 61:6, pages 838-853.
Crossref
N. A. Karoli, A. V. Borodkin & A. P. Rebrov. (2021) The use of beta-blockers in patients with chronic obstructive pulmonary disease and chronic heart failure in real clinical practice. South Russian Journal of Therapeutic Practice 2:1, pages 70-75.
Crossref
Daniel B Rasmussen, Uffe Bodtger, Morten Lamberts, Christian Torp-Pedersen, Gunnar Gislason, Peter Lange & Magnus T Jensen. (2020) Beta-blocker use and acute exacerbations of COPD following myocardial infarction: a Danish nationwide cohort study. Thorax 75:11, pages 928-933.
Crossref
Gianfranco Sinagra, Ugo Corrà, Mauro Contini, Damiano Magrì, Stefania Paolillo, Pasquale Perrone Filardi, Susanna Sciomer, Roberto Badagliacca & Piergiuseppe Agostoni. (2020) Choosing among β-blockers in heart failure patients according to β-receptors’ location and functions in the cardiopulmonary system. Pharmacological Research 156, pages 104785.
Crossref
Jagjit Singh. (2020) Beta-blockers: A tale of triumphs, trials, and tribulations. International Journal of Applied and Basic Medical Research 10:1, pages 1.
Crossref
Tafadzwa F. Mtisi & William H. Frishman. (2020) Beta Adrenergic Blocker Use in Patients With Chronic Obstructive Pulmonary Disease and Concurrent Chronic Heart Failure With a Low Ejection Fraction. Cardiology in Review 28:1, pages 20-25.
Crossref
Tracey L. Mersfelder & Dane L. Shiltz. (2019) β-Blockers and the Rate of Chronic Obstructive Pulmonary Disease Exacerbations. Annals of Pharmacotherapy 53:12, pages 1249-1258.
Crossref
Maurizio Sessa, Annamaria Mascolo, Daniel Bech Rasmussen, Kristian Kragholm, Magnus Thorsten Jensen, Liberata Sportiello, Concetta Rafaniello, Giuseppe Michele Tari, Claudia Pagliaro, Morten Andersen, Francesco Rossi & Annalisa Capuano. (2019) Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study. Scientific Reports 9:1.
Crossref
Wen-Hwa Wang, Chin-Chang Cheng, Guang-Yuan Mar, Kai-Che Wei, Wei-Chun Huang & Chun-Peng Liu. (2019) Improving outcomes in chronic obstructive pulmonary disease by taking beta-blockers after acute myocardial infarction: a nationwide observational study. Heart and Vessels 34:7, pages 1158-1167.
Crossref
Cheng-Yi Wang, Ya-Hui Wang & Chih-Cheng Lai. (2019) Different Non-selective β-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease. EClinicalMedicine 10, pages 3.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.